Interscope, a company out of Worcester, MA, landed FDA clearance for its EndoRotor device that, in a single step, dissects, resects, and retrieves mucosal lesions within the GI tract. In the U.S. the device is indicated for use within the colon, shaving off diseased mucosa in conjunction with endoscopic mucosal resectiont (EMR), and sucking up the debris to remove it from the body. These days lesions are typically removed using snares and forceps, tools that in many cases leave pieces of the targeted lesions intact.
The EndoRotor allows for precise targeting of tissues to address incomplete resection.
The EndoRotor provides a non-thermal technique and does not carry the risk for thermal spread or cautery artifacts. Procedures are done using prophylactic epinephrine to provide hemostasis.
The device, which is being launched in the U.S. this week at the Digestive Disease Week in Chicago, received European regulatory approval back in October of 2015 and is in regular use at a number of hospitals in Germany, UK, Holland, Switzerland, and Austria.
Here’s a video that demonstrates how the EndoRotor is used within the colon:
Product page: EndoRotor…